UT Southwestern Medical Center-Dallas
Welcome,         Profile    Billing    Logout  
 5 Trials 
20 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rahimi, Asal
RAPS, NCT06444269: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI () and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: Trial

Recruiting
2
53
US
Radiomics on MRI, microbubble CEUS Contrast Enhanced Ultrasound (CEUS)
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/28
NCT04040569: A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer

Active, not recruiting
1
45
US
Radiomics on MRI
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/27
NCT02685332: Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA

Active, not recruiting
1
30
US
Stereotactic Radiation, SB-PBI
University of Texas Southwestern Medical Center
Early Stage Breast Cancer
06/26
06/26
NCT02170181: Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation

Recruiting
N/A
5000
NA
SBRT, Stereotactic body radiation therapy
University of Texas Southwestern Medical Center
Cancer Patients Receiving Stereotactic Body RTX
12/26
12/26
GCC 1876, NCT03562273: GammaPod Registry and Quality of Life Nomogram

Recruiting
N/A
160
US
Quality Of Life Sizing Nomogram, GammaPod Quality Of Life Sizing Nomogram
University of Maryland, Baltimore, University of Texas, Southwestern Medical Center at Dallas
Breast Cancer Female
12/26
12/27
NCT03581136: Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod

Active, not recruiting
N/A
74
US
Dose Fractionation
University of Texas Southwestern Medical Center
Breast Cancer
05/28
06/30
Neufeld, Sarah
POTEN-C, NCT03525262: Prostate Oncologic Therapy While Ensuring Neurovascular Conservation

Active, not recruiting
2
124
US
30Gy (Gray) planning target volume (PTV)
University of Texas Southwestern Medical Center, Boston Scientific Corporation
Prostate Cancer Adenocarcinoma
05/27
05/27
PROMISE, NCT05148078: Pediatric Radiation Oncology With Movie Induced Sedation Effect

Recruiting
2
30
US
PROMISE (Pediatric Radiation Oncology with Movie Induced Sedation Effect)
University of Texas Southwestern Medical Center
Pediatric Cancer
08/25
09/25
RAPS, NCT06444269: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI () and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: Trial

Recruiting
2
53
US
Radiomics on MRI, microbubble CEUS Contrast Enhanced Ultrasound (CEUS)
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/28
NCT06477692: Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

Recruiting
2
80
US
ENI using IMRT with or without chemotherapy, cisplatin, cetuximab, or carboplatin- paclitaxel), INRT, ENI
University of Texas Southwestern Medical Center, National Cancer Institute (NCI)
Head and Neck Cancer
07/28
07/28
KEVLARx, NCT05966194: RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Recruiting
2
216
US
RRx-001, Intensity Modulated Radiation Therapy (IMRT), Cisplatin for injection 100 mg/m2
EpicentRx, Inc.
Oral Mucositis
07/25
10/25
NCT04786093: Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC

Active, not recruiting
2
52
US
Stereotactic radiation therapy, Durvalumab
University of Texas Southwestern Medical Center
Non Small Cell Lung Cancer
05/26
05/27
NCT05021237: Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer

Recruiting
2
30
US
Ultra-fractionated radiation therapy
University of Texas Southwestern Medical Center, Elekta Limited
Stage IV Cervical Cancer FIGO 2018, Adenosquamous Carcinoma of Cervix, Cervical Cancer, Metastasis
08/28
08/28
HYHOPE, NCT04580446: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer

Completed
1
24
US
Hypofractionated intensity modulated radiotherapy
University of Texas Southwestern Medical Center, Gateway for Cancer Research
Human Papillomavirus-Related Carcinoma, Oropharyngeal Cancer
12/24
12/24
NCT06044857: PSMA PET Response Guided SabR in High Risk Pca

Recruiting
1
20
US
68-Ga PSMA11, Illucix, Telix
University of Texas Southwestern Medical Center, Once Upon a Time Foundation, Telix Pharmaceuticals (Innovations) Pty Limited
Prostate Adenocarcinoma
11/26
11/26
ARTIA-Cervix, NCT05197881: Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix

Recruiting
N/A
125
US
Varian Ethos Adaptive Radiation Therapy
Varian, a Siemens Healthineers Company
Cervical Cancer by FIGO Stage 2018
05/26
05/28
NCT00992303: Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Recruiting
N/A
10000
US
biologic sample preservation procedure, medical chart review, questionnaire administration
University of Texas Southwestern Medical Center
Unspecified Adult Solid Tumor, Protocol Specific
12/29
12/29
NCT06353321: Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1

Recruiting
N/A
25
US
PET-CT imaging subsystem of the RefleXion X1 System Device
University of Texas Southwestern Medical Center, RefleXion Medical
Prostate Cancer
12/25
12/25
G-FORCE, NCT06080503: Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

Recruiting
N/A
67
US
LT-SABR, IMRT
University of Texas Southwestern Medical Center
Laryngeal Carcinoma
11/28
03/29
NCT03617237: Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation

Recruiting
N/A
10000
US
Retrospective Populations
University of Texas Southwestern Medical Center
Cancer
07/30
04/32
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rahimi, Asal
RAPS, NCT06444269: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI () and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: Trial

Recruiting
2
53
US
Radiomics on MRI, microbubble CEUS Contrast Enhanced Ultrasound (CEUS)
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/28
NCT04040569: A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer

Active, not recruiting
1
45
US
Radiomics on MRI
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/27
NCT02685332: Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA

Active, not recruiting
1
30
US
Stereotactic Radiation, SB-PBI
University of Texas Southwestern Medical Center
Early Stage Breast Cancer
06/26
06/26
NCT02170181: Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation

Recruiting
N/A
5000
NA
SBRT, Stereotactic body radiation therapy
University of Texas Southwestern Medical Center
Cancer Patients Receiving Stereotactic Body RTX
12/26
12/26
GCC 1876, NCT03562273: GammaPod Registry and Quality of Life Nomogram

Recruiting
N/A
160
US
Quality Of Life Sizing Nomogram, GammaPod Quality Of Life Sizing Nomogram
University of Maryland, Baltimore, University of Texas, Southwestern Medical Center at Dallas
Breast Cancer Female
12/26
12/27
NCT03581136: Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod

Active, not recruiting
N/A
74
US
Dose Fractionation
University of Texas Southwestern Medical Center
Breast Cancer
05/28
06/30
Neufeld, Sarah
POTEN-C, NCT03525262: Prostate Oncologic Therapy While Ensuring Neurovascular Conservation

Active, not recruiting
2
124
US
30Gy (Gray) planning target volume (PTV)
University of Texas Southwestern Medical Center, Boston Scientific Corporation
Prostate Cancer Adenocarcinoma
05/27
05/27
PROMISE, NCT05148078: Pediatric Radiation Oncology With Movie Induced Sedation Effect

Recruiting
2
30
US
PROMISE (Pediatric Radiation Oncology with Movie Induced Sedation Effect)
University of Texas Southwestern Medical Center
Pediatric Cancer
08/25
09/25
RAPS, NCT06444269: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI () and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: Trial

Recruiting
2
53
US
Radiomics on MRI, microbubble CEUS Contrast Enhanced Ultrasound (CEUS)
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/28
NCT06477692: Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

Recruiting
2
80
US
ENI using IMRT with or without chemotherapy, cisplatin, cetuximab, or carboplatin- paclitaxel), INRT, ENI
University of Texas Southwestern Medical Center, National Cancer Institute (NCI)
Head and Neck Cancer
07/28
07/28
KEVLARx, NCT05966194: RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Recruiting
2
216
US
RRx-001, Intensity Modulated Radiation Therapy (IMRT), Cisplatin for injection 100 mg/m2
EpicentRx, Inc.
Oral Mucositis
07/25
10/25
NCT04786093: Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC

Active, not recruiting
2
52
US
Stereotactic radiation therapy, Durvalumab
University of Texas Southwestern Medical Center
Non Small Cell Lung Cancer
05/26
05/27
NCT05021237: Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer

Recruiting
2
30
US
Ultra-fractionated radiation therapy
University of Texas Southwestern Medical Center, Elekta Limited
Stage IV Cervical Cancer FIGO 2018, Adenosquamous Carcinoma of Cervix, Cervical Cancer, Metastasis
08/28
08/28
HYHOPE, NCT04580446: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer

Completed
1
24
US
Hypofractionated intensity modulated radiotherapy
University of Texas Southwestern Medical Center, Gateway for Cancer Research
Human Papillomavirus-Related Carcinoma, Oropharyngeal Cancer
12/24
12/24
NCT06044857: PSMA PET Response Guided SabR in High Risk Pca

Recruiting
1
20
US
68-Ga PSMA11, Illucix, Telix
University of Texas Southwestern Medical Center, Once Upon a Time Foundation, Telix Pharmaceuticals (Innovations) Pty Limited
Prostate Adenocarcinoma
11/26
11/26
ARTIA-Cervix, NCT05197881: Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix

Recruiting
N/A
125
US
Varian Ethos Adaptive Radiation Therapy
Varian, a Siemens Healthineers Company
Cervical Cancer by FIGO Stage 2018
05/26
05/28
NCT00992303: Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Recruiting
N/A
10000
US
biologic sample preservation procedure, medical chart review, questionnaire administration
University of Texas Southwestern Medical Center
Unspecified Adult Solid Tumor, Protocol Specific
12/29
12/29
NCT06353321: Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1

Recruiting
N/A
25
US
PET-CT imaging subsystem of the RefleXion X1 System Device
University of Texas Southwestern Medical Center, RefleXion Medical
Prostate Cancer
12/25
12/25
G-FORCE, NCT06080503: Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

Recruiting
N/A
67
US
LT-SABR, IMRT
University of Texas Southwestern Medical Center
Laryngeal Carcinoma
11/28
03/29
NCT03617237: Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation

Recruiting
N/A
10000
US
Retrospective Populations
University of Texas Southwestern Medical Center
Cancer
07/30
04/32

Download Options